About the Company
We do not have any company description for Janux Therapeutics, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $JANX News
Which Is a Better Investment, Janux Therapeutics Inc or BIO-TECHNE Corp Stock?
Learn more about whether Janux Therapeutics Inc or BIO-TECHNE Corp is a better investment based on AAII's A+ Investor grades, ...
Janux (JANX) Rises Almost 50% in a Week on Buyout Rumors
Shares of cancer-biotech Janux Therapeutics, Inc. JANX have surged close to 50% in the past week, following a report issued ...
Why Is Cancer-Focused Janux Therapeutics Stock Trading Higher On Thursday?
Janux Therapeutics Inc (NASDAQ:JANX) shares are trading higher following Wednesday’s reports suggesting the company is ...
A Glimpse Into The Expert Outlook On Janux Therapeutics Through 6 Analysts
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $63.83, along ...
Janux Therapeutics Inc (JANX) Shares Soar Above 1-Year High
Reardon Tighe, the Acting Chief Financial Officer of Janux Therapeutics Inc, purchase 849,854 shares at $5.87 during a trade that took place back on Nov 13 ’23, which means that Reardon Tighe is ...
Commit To Purchase Janux Therapeutics At $25, Earn 26.5% Annualized Using Options
Investors eyeing a purchase of Janux Therapeutics Inc (Symbol: JANX) shares, but tentative about paying the going market price of $35.70/share, might benefit from considering selling puts among ...
Janux Therapeutics Inc Ordinary Shares
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Janux Therapeutics, Inc. (JANX)
Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...
Janux Therapeutics Inc Ordinary Shares JANX
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Loading the latest forecasts...